BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

Overview
Date Founded

1999

Headquarters

Block 11, Beishan Industrial Zone,Yantian District,Shenzhen, Guangdong 518083

Type of Company

Public

Employees (Worldwide)

3,585

Industries

Biotechnology
Hospitals & Patient Services
Computer Software
Market & Policy Research

Company Description

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Executives & Employees

Co-Founder

Chief Executive Officer

Chief Financial Officer & Chief Accountant

Global Head of R&D

Senior Director of Business Development & Communications

Director

Director of Human Resources & Chief Human Officer

Deputy Director

Board of Directors

Co-Founder at BGI Genomics Co., Ltd.

Chief Executive Officer at BGI Genomics Co., Ltd.

Deputy Director-EDP Center at Xiamen University

Managing Director at China Everbright Holdings Co. Ltd.

Independent Director at BGI Genomics Co., Ltd.

Paths to BGI Genomics Co., Ltd.
Potential Connections via
Relationship Science
You
BGI Genomics Co., Ltd.
Owners & Shareholders
Details Hidden

WJAsset is a risk-averse manager which seeks to achieve consistent long-term returns. The firm manages an index fund tracking the SSE 180 index, a guaranteed fund using dynamic portfolio insurance strategies such as CPPI and TIPP, an equity fund invested in the utilities sector and using an active enhanced index strategy, and a money market fund. Their investment process is quantitative, complemented by qualitative judgment.

Details Hidden

JX Asset Management Co.,Ltd is a private company headquartered in Shenzhen, China. The firm provides investment advice. It was founded in 2015. Ke Sheng Yin is the current CEO of the firm.

Details Hidden

HFM has their investment decision-making, risk control team and research and development department. The investment decision making team is responsible for the major investment decisions such as fund asset allocation. The risk control team is responsible for the risk prevention measure proposal for the investment portfolio. The research and development department is responsible for the construction and maintenance of fund stock pool. The firm combines top-down and bottom-up approaches and concentrates investments in specific sectors.

Recent Transactions
Details Hidden

BGI Genomics Co., Ltd. issued CNY Ordinary Shares

Details Hidden

BGI Americas Corp., BGI Genomics Co., Ltd. purchase Complete Genomics, Inc.

Transaction Advisors
Public Relations

Advised onBGI Genomics Co., Ltd., BGI Americas Corp. purchase Complete Genomics, Inc.

Sponsor

Advised onBGI Genomics Co., Ltd. issued CNY Ordinary Shares

Investment Advisor

Advised onBGI Genomics Co., Ltd., BGI Americas Corp. purchase Complete Genomics, Inc.

Legal Advisor

Advised onBGI Genomics Co., Ltd. issued CNY Ordinary Shares

Associate

Advised onBGI Genomics Co., Ltd. issued CNY Ordinary Shares

Associate

Advised onBGI Genomics Co., Ltd. issued CNY Ordinary Shares

Clients

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The firm also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. The company was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Key Stats and Financials As of 2019
Market Capitalization
$8.84B
Total Enterprise Value
$3.89B
Earnings Per Share
$0.1
Net Profit
$40.2M
EBITDA
$75.7M
Total Debt
$55.9M
Total Equity
$641M
Revenue
$407M
Three Year Compounded Annual Growth Rate Of Revenue
17.87%
Debt TEV
0.01x
TEVNet Income
96.77x
Enterprise Value EBITDAOperating
51.44x
Enterprise Value / Sales
9.58x
EBITDAMargin
18.62%
Investments
Details Hidden

Beijing Geneplus Technology Co., Ltd. engages in the provision of tumor gene detection services. It provides medication, monitoring, postoperative recurrence monitoring, risk prediction, and early detection services. Its products include tumor precise drug gene detection for lung cancer, breast cancer, gastrointestinal tumors, and whole cancer species; as well as genetic tumor gene detection for hereditary breast and ovarian cancer, hereditary gastrointestinal cancer, and hereditary tumor. The company was founded by Xin Yi and Ling Yang on April 23, 2015 and is headquartered in Beijing, China.

Details Hidden

Beijing Judao Technology Co. Ltd. is a company headquartered in Beijing, China, that operates as a precision medical data platform. The firm was founded in 2014 by Le Wang and Xia Li.

Details Hidden

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses SAPIENTIA technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Investors
Details Hidden

Huaxia Life Insurance Co,. Ltd. engages in the provision of insurance products such as annuity insurance, pension insurance, and health insurance. The company was founded in December 2006 and is headquartered in Beijing, China.

Details Hidden

NLVCDL is a hands-on manager which focuses on early- and expansion-stage businesses in the technology, media, telecommunications, services and consumer products sectors, primarily in China, but they also invest in Korea. Their technology investment themes include innovations in the IT sector and vertical industries where technology plays a key role. In the consumer-related sector, they target capital-efficient companies offering products or services for the expanding Chinese middle class. They also have a particular interest in China-based companies addressing the global market.The firm follows a hands-on investment approach and actively promotes the growth of their portfolio companies through the provision of advisory consulting, strategic support and introductions to potential business partners. Their exit strategies include listing on the NASDAQ stock exchange.

Details Hidden

Professor at Human Genome Sequencing Center

Suppliers
II-VI Incorporated Aerospace & Defense | Saxonburg, PA

II-VI, Inc. engages in the development, refinement, manufacturing, and marketing of engineered materials and opto-electronic components and devices for precision in the field of industrial materials processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences, and automotive applications and markets. It operates through the following segments: Photonic Solutions and Compound Semiconductors. The Photonic Solutions segment manufactures crystal materials, optics, microchip lasers and optoelectronic modules for use in optical communication networks and other diverse consumer and commercial applications, pump lasers, optical isolators, and optical amplifiers and micro-optics for optical amplifiers, for both terrestrial and submarine applications within the optical communications market. The Compound Semiconductors segment designs, manufactures and markets optical and electro-optical components and materials, infrared optical components and high-precision optical assemblies for aerospace and defense, medical and commercial laser imaging applications, semiconductor lasers and detectors for optical interconnects and sensing applications, unique engineered materials for thermoelectric and silicon carbide applications servicing the semiconductor, aerospace and defense and medical markets. The company was founded Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Natera, Inc. Hospitals & Patient Services | San Carlos, CA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Ronglian Group Ltd. IT Consulting & Services | Beijing, China

Ronglian Group Ltd. engages in design, development, and sale of information technology systems. It provides data center and information technology infrastructure solutions, cloud computing, enterprise mobile applications, software development, business consulting and other professional services. The company was founded by Dong Hui Wang on March 12, 2001 and is headquartered in Beijing, China.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

bioMérieux SA Medical Products & Equipment - Marcy l’etoile, France

bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The firm develops testing. detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by BGI Genomics Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of BGI Genomics Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and BGI Genomics Co., Ltd..